← Back

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

This grant supports multi-site exploratory or confirmatory clinical trials of promising stroke interventions, as well as biomarker or outcome-measure validation studies that prepare for such trials, and ancillary studies that add scientific aims to ongoing StrokeNet projects. Successful applicants will conduct their work within the NIH StrokeNet infrastructure.

Amount
Not stated
Type
Grant

Key facts

Key facts for NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
AmountNot stated
IssuerNational Institutes of Health
Who can applySmall businesses, companies, universities and 7 more
SectorsHealthTech
DeadlineCloses 19 Nov 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 2 days ago

  1. 85 days agoagentImported from the official source